• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, March 30, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Researchers discovered new information on the regulation of cancer cell motility

Bioengineer by Bioengineer
August 19, 2020
in Health
Reading Time: 2 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Päivi Koskinen, University of Turku

PIM kinases are enzymes that promote metastatic growth and spread of cancer cells. Researchers from the University of Turku, Finland, have obtained new information on how the PIM kinases enhance cancer cell motility by regulating the formation of actin fibres in the cytoskeleton. The published results support the development of PIM-targeted therapies to prevent metastasis formation in cancer patients.

It is critical for the survival of cancer patients, whether the cancer cells remain in their primary location or start migrating around the body to form metastases into bones and other vital organs. In order to be able to prevent metastasis formation, more information is needed about the factors regulating cancer cell motility.

– We had previously observed that PIM kinases promote and PIM-inhibitory compounds reduce migration of prostate cancer cells, but now we found a new mechanism to explain these observations, says the leader of the research group, Dr. Päivi Koskinen from the Department of Biology at the University of Turku.

Cellular movements are motorised by cytoskeletal actin fibres which are constantly polymerised or depolymerised, unless they are capped by proteins that protect the ends of the fibres.

– We demonstrated that via phosphorylation, PIM kinases modify actin capping proteins so that they cannot bind to actin polymers. As a consequence, actin processing as well as cell motility are enhanced, describes PhD Niina Santio who had the main responsibility for the experimental research.

– By contrast, in the presence of PIM inhibitors, cells stuck to each other and did not move much.

Video Abstract Visualises the Results

The results published in the Cell Communication and Signaling journal help to better understand the pro-metastatic effects of both the PIM kinases and the anti-metastatic PIM inhibitors.

In addition to written and graphic abstracts, the research group also used a video abstract for the first time to present their data.

– A visual abstract is a nice way to summarise the main message of the research into a single figure. Now, we also had the opportunity to wrap up our results into a short informative video which was finalised by an expert team provided by the journal, explains Päivi Koskinen.

###

The video abstract: https://youtu.be/iLwiV1GRXJY

Media Contact
Päivi Koskinen
[email protected]

Original Source

https://www.utu.fi/en/news/press-release/researchers-discovered-new-information-on-the-regulation-of-cancer-cell-motility

Related Journal Article

http://dx.doi.org/10.1186/s12964-020-00618-6

Tags: cancerCell BiologyMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Dr. Yangzhi Zhu of Terasaki Institute Receives American Heart Association Career Development Award for Pioneering Translational Biosensing Research

March 30, 2026

Tetracenomycin Y: Rare Actinomycete’s Plant Growth Booster

March 30, 2026

Advancing Precision Medicine: Boosting Genetic Diagnoses for More Patients

March 30, 2026

Self-Evolving AI Transforms Autonomous Biomedical Data Analysis

March 30, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1005 shares
    Share 397 Tweet 248
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Advancements in EV Battery Technology to Surpass Climate Change-Induced Degradation

    45 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Dr. Yangzhi Zhu of Terasaki Institute Receives American Heart Association Career Development Award for Pioneering Translational Biosensing Research

Innovative Analytical Technique Uncovers Drug Combination Effects in Leukemia, Paving the Way for Precision-Engineered Combinatorial Treatments

Uncovering the Quantum Needle Hidden in a Haystack

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.